This piece mentions Thirdwave Technologies (NASDAQ:TWTI)
http://www.c3ktogo.com/news-video/?mgid=14318
MTWTI has a market cap = US$400m and currently trading at 5 year highs.
Deutshe Bank this week initiated research coverage with a Strong Buy recommendation.
TWT has 2 HPV tests, a high risk HPV test and a Type 16 & 18 HPV genotyping test. Types 16 & 18 cause 70% of all cervical cancers. There are another 12 types that cause the other 30% of cervical cancers.
GBI's test detects AND genotypes ALL 14 high risk types (ie. it specifies the other 12 risk types that cause 30% of all cervical cancers as well!)
If you were a woman which test would you want?
One that genotypes 70% of the HPV types that cause cervical cancer or one that genotypes 100%?
If GBI can even be half the market cp of TWTI = $2.10 per share...all aboard!
GBI Price at posting:
0.0¢ Sentiment: ST Buy Disclosure: Not Held
